Fig. 1.
Fig. 1. Ellipsometry studies of effects of aPL IgG and cofactor on displacement of annexin-V from PS/PC phospholipid bilayers. (A) Shows the rapid adsorption of annexin-V to the PS/PC (30%/70%) phospholipid bilayer. Treatment with EDTA and measurement of the desorption of this protein can be used to measure the amount of annexin-V on the phospholipid surface. As shown, this calcium-dependent binding protein is completely desorbed from the phospholipid surface by addition of 6 mmol/L EDTA. (B) Shows that incubation of the annexin-V–coated phospholipid bilayer with a polyclonal human aPL IgG in the absence of β2-GPI does not displace the annexin-V, ie, the quantity of annexin-V desorbed after treatment with EDTA matches the quantity of annexin-V, which had originally adsorbed. (C) Incubation of the annexin-V–coated phospholipid bilayer with β2-GPI followed by polyclonal aPL IgG results in a significant reduction of the quantity of annexin-V on the bilayer. This is reflected by the marked reduction of the amount of annexin-V, which desorbs after treatment with EDTA. (D) In contrast, treatment of the phospholipid bilayer with the β2-GPI cofactor followed by a control (non-aPL) IgG fraction does not change the quantity of annexin-V on the phospholipid surface at all, ie, the quantity of annexin-V that is desorbed by treatment with EDTA is the same as the quantity that had been adsorbed in the first place.

Ellipsometry studies of effects of aPL IgG and cofactor on displacement of annexin-V from PS/PC phospholipid bilayers. (A) Shows the rapid adsorption of annexin-V to the PS/PC (30%/70%) phospholipid bilayer. Treatment with EDTA and measurement of the desorption of this protein can be used to measure the amount of annexin-V on the phospholipid surface. As shown, this calcium-dependent binding protein is completely desorbed from the phospholipid surface by addition of 6 mmol/L EDTA. (B) Shows that incubation of the annexin-V–coated phospholipid bilayer with a polyclonal human aPL IgG in the absence of β2-GPI does not displace the annexin-V, ie, the quantity of annexin-V desorbed after treatment with EDTA matches the quantity of annexin-V, which had originally adsorbed. (C) Incubation of the annexin-V–coated phospholipid bilayer with β2-GPI followed by polyclonal aPL IgG results in a significant reduction of the quantity of annexin-V on the bilayer. This is reflected by the marked reduction of the amount of annexin-V, which desorbs after treatment with EDTA. (D) In contrast, treatment of the phospholipid bilayer with the β2-GPI cofactor followed by a control (non-aPL) IgG fraction does not change the quantity of annexin-V on the phospholipid surface at all, ie, the quantity of annexin-V that is desorbed by treatment with EDTA is the same as the quantity that had been adsorbed in the first place.

Close Modal

or Create an Account

Close Modal
Close Modal